Oil, Gas and Consumable Fuels
Company Overview of Solazyme, Inc.
Solazyme, Inc. manufactures and sells renewable oils and other bioproducts. Its proprietary technology transforms a range of plant-based sugars into triglyceride oils and other bioproducts. The company offers renewable tailored oils, such as oleic oils that provide sustainable solutions within the food, lubricant, functional fluid, and oleo chemical markets; and drop-in replacements and blend stocks for marine, motor vehicle and jet fuels, as well as replacements for petrochemicals. It is also provides fuels, including SoladieselBD, a fatty acid methyl ester; SoladieselRD, a hydro-treated renewable diesel; SoladieselHRD-76, a military grade hydrotreated renewable diesel; and SolajetD7566 and...
225 Gateway Boulevard
South San Francisco, CA 94080
Founded in 2003
Key Executives for Solazyme, Inc.
Total Annual Compensation: $545.0K
Chief Financial Officer
Total Annual Compensation: $360.7K
Senior Vice President
Total Annual Compensation: $321.4K
Chief Technology Officer
Total Annual Compensation: $360.7K
Total Annual Compensation: $412.0K
Compensation as of Fiscal Year 2013.
Solazyme, Inc. Key Developments
Solazyme and AkzoNobel Expand Joint Development Agreement
Aug 11 14
Solazyme, Inc. and Akzo Nobel N.V. have expanded their previous joint development agreement. The expansion provides for funded development, as well as agreed key terms for a multi-year supply agreement targeting annual supply of up to 10,000 MT of renewable Tailored algal oils, pending successful product development. The parties expect that the algal oil under the joint development agreement would be able to replace both petroleum and palm oil-derived chemicals. The target product is designed to have improved functional and environmental performance, as well as a lower overall cost to AkzoNobel.
Solazyme, Inc. Presents at 16th Annual Pacific Crest Global Technology Leadership Forum, Aug-12-2014 02:30 PM
Aug 7 14
Solazyme, Inc. Presents at 16th Annual Pacific Crest Global Technology Leadership Forum, Aug-12-2014 02:30 PM. Venue: The Sonnenalp Hotel, 20 Vail Road, Vail, CO 81657, United States.
Solazyme, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2014
Jul 30 14
Solazyme, Inc. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2014. Total revenue for the second quarter of 2014 was $15.9 million compared with $11.2 million in the second quarter of 2013, an increase of 43%. Second quarter GAAP net loss was $42.9 million, which compares with net loss of $25.8 million in the prior year period. On a non-GAAP basis, the net loss was $32.9 million for the second quarter of 2014, compared with net loss of $17.4 million in the prior year quarter. Gaap net loss per share was at $0.56 per basic and diluted share against $0.42 per share reported last year. Loss from operations was $32,232,000 compared to $20,672,000 a year ago. Net loss (non-GAAP) per share was at $0.43 per basic and diluted share compared to $0.28 per basic and diluted share a year ago.
For the six months period, the company reported total revenues of $28,330,000 compared to $17,855,000 a year ago. Loss from operations was $64,673,000 compared to $44,032,000 a year ago. Net loss was $77,598,000 or $1.07 per basic and diluted share compared to $52,350,000 or $0.85 per basic and diluted share a year ago. Net loss (non-GAAP) was $63,402,000 or $0.87 per basic and diluted share compared to $38,862,000 or $0.63 per basic and diluted share a year ago.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|